Yi-Wei Merges with Jianya; Lin Han-fei: If Major Shareholder Exercises Dissenting Rights, Shares Will Be Bought Back According to Law
NQ Score
96/100
AI Summary (NQ-processed)
Yi-Wei Bio-medical Chairman Lin Han-fei stated that if the share swap between Yi-Wei and Jianya is approved and Jianya's major shareholder Johnson exercises dissenting rights to buy back its shares, Yi-Wei will legally repurchase the relevant shares. Jianya will hold a shareholder meeting on April 22nd, and Johnson has expressed doubts about the merger's financial stability and is seeking shareholder support to block the merger.
AI analysis data is not yet available.